Mariner

Mariner’s Xeris Biopharma Holdings XERS Stock Holding History

Mariner’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$134K	Buy	+23,081	New	+$153K	﹤0.01%	3268
2025 Q4	–	Sell	-10,404	Closed	-$84.7K	–	3833
2025 Q3	$84.7K	Sell	10,404 -1,333	-11%	-$8.86K	﹤0.01%	3389
2025 Q2	$54.8K	Sell	11,737 -29,617	-72%	-$136K	﹤0.01%	3334
2025 Q1	$227K	Buy	41,354 +11,054	+36%	+$44.6K	﹤0.01%	2892
2024 Q4	$103K	Hold	30,300	–	–	﹤0.01%	3180
2024 Q3	$86.4K	Sell	30,300 -36,755	-55%	-$94.4K	﹤0.01%	3116
2024 Q2	$151K	Sell	67,055 -31,016	-32%	-$62.5K	﹤0.01%	2864
2024 Q1	$217K	Sell	98,071 -31,319	-24%	-$81K	﹤0.01%	2702
2023 Q4	$304K	Sell	129,390 -62,354	-33%	-$115K	﹤0.01%	2341
2023 Q3	$357K	Buy	191,744 +10,857	+6%	+$24.9K	﹤0.01%	2006
2023 Q2	$474K	Sell	180,887 -350	-0.2%	-$891	﹤0.01%	1785
2023 Q1	$295K	Buy	181,237 +150,923	+498%	+$189K	﹤0.01%	2081
2022 Q4	$40K	Buy	30,314 +14	+0%	+$20	﹤0.01%	2631
2022 Q3	$47K	Buy	+30,300	New	+$50.1K	﹤0.01%	2317

Other funds holding XERS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return